Klaus‐Peter Liesenkötter
Klaus‐Peter Liesenkötter publishes mostly in Endocrinology, Diabetes and Metabolism, Molecular Biology and Pediatrics, Perinatology and Child Health, on topics such as Thyroid Disorders and Treatments, Sexual Differentiation and Disorders and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities.
- World rank
- #4,674,133 of 7,710,434 ranked researchers
- Rank in Germany
- #238,600 of 364,343
- Works
- 18
- Citations
- 331
- Citations per work
- 18.4
What does Klaus‐Peter Liesenkötter research?
Klaus‐Peter Liesenkötter's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (15%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1054.8%
- Medicine1054.8%
- Everything else530.1%
- Life Sciences315.1%
- 1Endocrinology, Diabetes and Metabolism34% of their works
- 2Molecular Biology9% of their works
- 3Pediatrics, Perinatology and Child Health9% of their works
- 4Genetics6% of their works
- 5Public Health, Environmental and Occupational Health6% of their works
- 6Surgery6% of their works
Research topics
- Thyroid Disorders and Treatments
- Sexual Differentiation and Disorders
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Diabetes Management and Research
- Neonatal Health and Biochemistry
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Thyroid Cancer Diagnosis and Treatment
- Obesity, Physical Activity, Diet
Which keywords describe Klaus‐Peter Liesenkötter's research?
The keywords of their largest research topics: Genetic Variants, Thyroid Dysfunction, Thyroid Hormone, Cardiovascular Disease, Congenital Adrenal Hyperplasia, Diabetes, Steroid 21-Hydroxylase Deficiency and Obesity.
- Thyroid Nodules
- Metabolic Syndrome
- Differentiated Thyroid Cancer
- X Chromosome Inactivation
- Neonatal Jaundice
- Hypoglycemia
- Obesity
- Diabetes
- Cardiovascular Disease
- Thyroid Dysfunction
- Genetic Variants
- Thyroid Hormone
- Congenital Adrenal Hyperplasia
- Steroid 21-Hydroxylase Deficiency
- Glucose-6-Phosphate Dehydrogenase Deficiency
- Insulin Therapy
- Sex Determination
- Childhood
- Insulin Resistance
- Overweight
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Genetic Variants82 topics
- Thyroid Dysfunction81 topic
- Thyroid Hormone81 topic
- Cardiovascular Disease52 topics
- Congenital Adrenal Hyperplasia51 topic
- Diabetes52 topics
- Steroid 21-Hydroxylase Deficiency51 topic
- Obesity42 topics
- Glucose-6-Phosphate Dehydrogenase Deficiency31 topic
- Hypoglycemia31 topic
- Insulin Therapy31 topic
- Neonatal Jaundice31 topic
- Sex Determination31 topic
- X Chromosome Inactivation31 topic
- Childhood21 topic
- Differentiated Thyroid Cancer21 topic
- Insulin Resistance21 topic
- Metabolic Syndrome21 topic
- Overweight21 topic
- Thyroid Nodules21 topic
Where does Klaus‐Peter Liesenkötter work?
Klaus‐Peter Liesenkötter's main affiliation in the publication record is Endokrinologikum, Germany.
How many publications and citations does Klaus‐Peter Liesenkötter have?
OpenAlex counts 18 works and 331 citations for Klaus‐Peter Liesenkötter, an h-index of 9, ranking #4,674,133 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Klaus‐Peter Liesenkötter. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.